Sarepta Therapeutics | Capitalisation Boursière





Capitalisation Boursière Changement Date
Acadia Pharmaceuticals USD 3.6B 10M 2025-09
Agios Pharmaceuticals USD 2.33B 402M 2025-09
Alnylam Pharmaceuticals USD 59.77B 17.25B 2025-09
Amgen USD 185.28B 33.35B 2026-02
Biogen USD 20.54B 2.13B 2025-09
BioMarin Pharmaceutical USD 10.4B 142M 2025-09
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 722.15B 16.64B 2025-09
Gilead Sciences USD 137.73B 184M 2025-09
Incyte USD 16.56B 3.38B 2025-09
Insmed USD 30.44B 11.35B 2025-09
Ionis Pharmaceuticals USD 10.43B 4.14B 2025-09
Moderna USD 10.09B 581M 2025-09
Neurocrine Biosciences USD 13.92B 1.48B 2025-09
Pfizer USD 145.87B 10.78B 2026-02
PTC Therapeutics USD 4.88B 1B 2025-09
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sarepta Therapeutics USD 2.02B 336M 2025-09
Tectonic Therapeutic USD 294M 77M 2025-09
Ultragenyx Pharmaceutical USD 2.9B 539M 2025-09
Vertex Pharmaceuticals USD 100.41B 13.91B 2025-09


Sarepta Therapeutics Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.